These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 20230013

  • 1. Molecular dynamics simulations of the HIV-1 integrase dimerization interface: guidelines for the design of a novel class of integrase inhibitors.
    Sippel M, Sotriffer CA.
    J Chem Inf Model; 2010 Apr 26; 50(4):604-14. PubMed ID: 20230013
    [Abstract] [Full Text] [Related]

  • 2. Crystal structure of the HIV-1 integrase core domain in complex with sucrose reveals details of an allosteric inhibitory binding site.
    Wielens J, Headey SJ, Jeevarajah D, Rhodes DI, Deadman J, Chalmers DK, Scanlon MJ, Parker MW.
    FEBS Lett; 2010 Apr 16; 584(8):1455-62. PubMed ID: 20227411
    [Abstract] [Full Text] [Related]

  • 3. Rational design of novel diketoacid-containing ferrocene inhibitors of HIV-1 integrase.
    da Silva CH, Del Ponte G, Neto AF, Taft CA.
    Bioorg Chem; 2005 Aug 16; 33(4):274-84. PubMed ID: 16023487
    [Abstract] [Full Text] [Related]

  • 4. Discovery of HIV-1 integrase inhibitors by pharmacophore searching.
    Hong H, Neamati N, Wang S, Nicklaus MC, Mazumder A, Zhao H, Burke TR, Pommier Y, Milne GW.
    J Med Chem; 1997 Mar 14; 40(6):930-6. PubMed ID: 9083481
    [Abstract] [Full Text] [Related]

  • 5. A platform for designing HIV integrase inhibitors. Part 1: 2-hydroxy-3-heteroaryl acrylic acid derivatives as novel HIV integrase inhibitor and modeling of hydrophilic and hydrophobic pharmacophores.
    Kawasuji T, Yoshinaga T, Sato A, Yodo M, Fujiwara T, Kiyama R.
    Bioorg Med Chem; 2006 Dec 15; 14(24):8430-45. PubMed ID: 17010623
    [Abstract] [Full Text] [Related]

  • 6. Triketoacid inhibitors of HIV-integrase: a new chemotype useful for probing the integrase pharmacophore.
    Walker MA, Johnson T, Ma Z, Banville J, Remillard R, Kim O, Zhang Y, Staab A, Wong H, Torri A, Samanta H, Lin Z, Deminie C, Terry B, Krystal M, Meanwell N.
    Bioorg Med Chem Lett; 2006 Jun 01; 16(11):2920-4. PubMed ID: 16546383
    [Abstract] [Full Text] [Related]

  • 7. Novel dimeric aryldiketo containing inhibitors of HIV-1 integrase: effects of the phenyl substituent and the linker orientation.
    Zeng LF, Jiang XH, Sanchez T, Zhang HS, Dayam R, Neamati N, Long YQ.
    Bioorg Med Chem; 2008 Aug 15; 16(16):7777-87. PubMed ID: 18644730
    [Abstract] [Full Text] [Related]

  • 8. Rational design of 2-pyrrolinones as inhibitors of HIV-1 integrase.
    Ma K, Wang P, Fu W, Wan X, Zhou L, Chu Y, Ye D.
    Bioorg Med Chem Lett; 2011 Nov 15; 21(22):6724-7. PubMed ID: 21996518
    [Abstract] [Full Text] [Related]

  • 9. Tn5 transposase as a useful platform to simulate HIV-1 integrase inhibitor binding mode.
    Barreca ML, Ortuso F, Iraci N, De Luca L, Alcaro S, Chimirri A.
    Biochem Biophys Res Commun; 2007 Nov 23; 363(3):554-60. PubMed ID: 17889829
    [Abstract] [Full Text] [Related]

  • 10. Discovery of small molecule HIV-1 integrase dimerization inhibitors.
    Tintori C, Demeulemeester J, Franchi L, Massa S, Debyser Z, Christ F, Botta M.
    Bioorg Med Chem Lett; 2012 May 01; 22(9):3109-14. PubMed ID: 22483582
    [Abstract] [Full Text] [Related]

  • 11. Insight into the inhibitory mechanism and binding mode between D77 and HIV-1 integrase by molecular modeling methods.
    Li P, Tan JJ, Liu M, Zhang XY, Chen WZ, Wang CX.
    J Biomol Struct Dyn; 2011 Oct 01; 29(2):311-23. PubMed ID: 21875151
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Azaindole hydroxamic acids are potent HIV-1 integrase inhibitors.
    Plewe MB, Butler SL, Dress KR, Hu Q, Johnson TW, Kuehler JE, Kuki A, Lam H, Liu W, Nowlin D, Peng Q, Rahavendran SV, Tanis SP, Tran KT, Wang H, Yang A, Zhang J.
    J Med Chem; 2009 Nov 26; 52(22):7211-9. PubMed ID: 19873974
    [Abstract] [Full Text] [Related]

  • 14. Salicylhydrazine-containing inhibitors of HIV-1 integrase: implication for a selective chelation in the integrase active site.
    Neamati N, Hong H, Owen JM, Sunder S, Winslow HE, Christensen JL, Zhao H, Burke TR, Milne GW, Pommier Y.
    J Med Chem; 1998 Aug 13; 41(17):3202-9. PubMed ID: 9703465
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Study on the molecular mechanism of inhibiting HIV-1 integrase by EBR28 peptide via molecular modeling approach.
    Hu JP, Gong XQ, Su JG, Chen WZ, Wang CX.
    Biophys Chem; 2008 Feb 13; 132(2-3):69-80. PubMed ID: 18037557
    [Abstract] [Full Text] [Related]

  • 18. Characterization and structural analysis of HIV-1 integrase conservation.
    Ceccherini-Silberstein F, Malet I, D'Arrigo R, Antinori A, Marcelin AG, Perno CF.
    AIDS Rev; 2009 Feb 13; 11(1):17-29. PubMed ID: 19290031
    [Abstract] [Full Text] [Related]

  • 19. In search of second-generation HIV integrase inhibitors: targeting integration beyond strand transfer.
    Voet AR, Maeyer MD, Debyser Z, Christ F.
    Future Med Chem; 2009 Oct 13; 1(7):1259-74. PubMed ID: 21426102
    [Abstract] [Full Text] [Related]

  • 20. Discovery and structure-activity relationship studies of a unique class of HIV-1 integrase inhibitors.
    Dayam R, Sanchez T, Neamati N.
    ChemMedChem; 2006 Feb 13; 1(2):238-44. PubMed ID: 16892356
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.